Any active autoimmune disease or a documented history of serious autoimmune disease within the past 5 years requiring immunosuppressive therapy.Xx_NEWLINE_xXOngoing or recent (within 5 years) evidence of autoimmune disease that required treatment with systemic immunosuppressive treatments;Xx_NEWLINE_xX10. Active or prior documented autoimmune disease within the past 2 years. Subjects with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment within the past 2 years are not excluded;Xx_NEWLINE_xXActive or prior documented autoimmune or inflammatory disorders within the past 3 years prior to the start of treatmentXx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 years (ie, with use of disease modifying agents, corticosteroids or immunosuppressive drugs).Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in the past 2 years (eg, with use of disease-modifying agents, anticoagulants, corticosteroids or immunosuppressive drugs).Xx_NEWLINE_xXHistory of known or suspected autoimmune disease with the specific exceptions of vitiligo, resolved childhood atopic dermatitis, psoriasis not requiring systemic treatment (within the past 2 years), and patients with a history of Grave's disease that are now euthyroid clinically and by laboratory testing.Xx_NEWLINE_xXHave active autoimmune disease or other syndrome that requires systemic steroids or autoimmune agents in the past 2 years.Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years. (Note: Patients with vitiligo, Grave disease, or psoriasis not requiring systemic treatment within the past 2 years are eligible.)Xx_NEWLINE_xXActive or prior documented autoimmune disease in the last 2 years. Participants with childhood atopy or asthma, vitiligo, alopecia, Hashimoto syndrome, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded.Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment within the last 2 years.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease-modifying agents, corticosteroids, or immunosuppressive drugs)Xx_NEWLINE_xXMay not have primary immunodeficiency or history of systemic autoimmune disease (e.g. Crohns, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years, including but not limited to systemic lupus erythematosus, sarcoidosis syndrome, or Wegener’s granulomatosis; NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment within the past 2 years are not excludedXx_NEWLINE_xXPatients with any history of known or suspected autoimmune disease with the specific exceptions of vitiligo, resolved childhood atopic dermatitis, psoriasis not requiring systemic treatment (within the past 2 years), and patients with a history of Grave's disease that are now euthyroid clinically and by laboratory testing.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in the past 2 years.Xx_NEWLINE_xXAutoimmune disease that required systemic treatmentXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in the past 2 yearsXx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: subjects with vitiligo, Graves’ disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded; patients with autoimmune endocrine disease adequately controlled with hormone replacement therapy are not excludedXx_NEWLINE_xXHas active or prior documented autoimmune disease within the past 2 years with the exceptions of vitiligo, Grave's disease, and/or psoriasis not requiring systemic treatmentXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXPatients with any history of known or suspected autoimmune disease with the specific exceptions of vitiligo, resolved childhood atopic dermatitis, psoriasis not requiring systemic treatment (within the past 2 years), and patients with a history of Grave's disease that are now euthyroid clinically and by laboratory testingXx_NEWLINE_xXHistory of autoimmune disease resulting in end organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollmentXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids, or immunosuppressive drugs). Replacement therapy is allowed.Xx_NEWLINE_xXHistory of autoimmune disease (e.g. Crohns, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: patients with vitiligo, Grave’s disease, type I diabetes mellitus or residual hypothyroidism due to autoimmune condition only requiring hormone replacement, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in the past 2 years (i.e. with use of disease modifying agents, corticosteroids or immunosuppressive drugs)Xx_NEWLINE_xXMay not have primary immunodeficiency or history of autoimmune disease (e.g. Crohns, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave’s disease, limited site eczema, or limited site plaque psoriasis not requiring systemic treatment (within the past 2 years), or other autoimmune conditions which are not expected to recur, are allowed after approval from the medical monitor or principal investigator (PI)Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: subjects with a history of autoimmune thyroid disease are not excluded; subjects with vitiligo or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years (i.e. with use of disease modifying agents, corticosteroids or immunosuppressive drugs).Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years NOTE: Subjects with vitiligo, Graves disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years.\r\n* NOTE: Subjects with vitiligo, Graves disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive autoimmune disease requiring systemic immune suppressive treatment within the past 2 years; NOTE: Subjects with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years. NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years NOTE: Subjects with vitiligo, Graves disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years. NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded.Xx_NEWLINE_xXHistory of autoimmune disease, requiring systemic immunosuppression and/or systemic disease modifying agents within the last 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years\r\n* NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune or inflammatory disorders requiring therapy within the past 3 years prior to the start of treatment; the following are exceptions to this criterion:\r\n* Vitiligo or alopecia;\r\n* Hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement; or \r\n* Psoriasis not requiring systemic treatmentXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXHas active or prior documented autoimmune disease within the past 2 years with the exceptions of vitiligo, Grave’s disease, and/or psoriasis not requiring systemic treatmentXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease (including inflammatory bowel disease, celiac disease, Wegener syndrome) within the past 2 years; subjects with childhood atopy or asthma, vitiligo, alopecia, Hashimoto syndrome, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented history of immunologic disorder including autoimmune disease within the past 2 years NOTE: subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in the past 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years. NOTE: Patients with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded.Xx_NEWLINE_xXActive autoimmune disease within the past 2 years, except for mild conditions not requiring systemic treatment, such as vitiligoXx_NEWLINE_xXHas active or prior autoimmune disease within the past 2 yearsXx_NEWLINE_xXSubject has an active autoimmune disease that has required systemic treatment within the past 2 years.Xx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 years (i.e. with use of disease modifying agents, corticosteroids or immunosuppressive drugs).Xx_NEWLINE_xXActive or inactive autoimmune disease or syndrome that has required systemic treatment in the past 2 years or receiving systemic therapy for an autoimmune or inflammatory disease.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids, or immunosuppressive drugs)Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years. NOTE: Patients with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded.Xx_NEWLINE_xXHas an active autoimmune disease requiring systemic treatment within the past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs) or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agentsXx_NEWLINE_xXActive or prior documented autoimmune disease; subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXHas an active autoimmune disease requiring systemic treatment within the past 3 months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.Xx_NEWLINE_xXPatients are not eligible who have a history of or active autoimmune disease within the past 3 years with the following exceptions:\r\n* Vitiligo or alopecia\r\n* Hypothyroidism on stable doses of thyroid replacement therapy\r\n* Psoriasis not requiring systemic therapy within the past 3 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years\r\n* NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXHas active autoimmune disease that required systemic treatment with use of disease modifying agents, corticosteroids or immunosuppressive drugsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment within the past 3 months or documented history of clinically severe autoimmune disease, or syndrome that requires systemic steroids or immunosuppressive agents.Xx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease-modifying agents, corticosteroids, or immunosuppressive drugs.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment in past 2 years.Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in the past 2 years.Xx_NEWLINE_xXActive autoimmune disease that required systemic treatment in the past 2 yearsXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment within the past 2 yearsXx_NEWLINE_xXHas an active autoimmune disease requiring systemic treatment within the past 2 years OR a documented history of clinically severe autoimmune disease.Xx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHistory of any autoimmune disease which required systemic therapy in the past 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the last 2 years.Xx_NEWLINE_xXEvidence of other active autoimmune disease that has required prolonged systemic treatment in past 2 years.Xx_NEWLINE_xXActive autoimmune disease that has required systemic therapy in the past 2 years with modifying agents, corticosteroids, or immunosuppressive agentsXx_NEWLINE_xXActive autoimmune disease requiring therapy within the past 2 years (Note: patients with vitiligo, Grave's disease or psoriasis not requiring systemic treatment within the past 2 years are not excluded);Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in the past 2 years (replacement therapies for hormone deficiencies are allowed)Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease-modifying agents, corticosteroids, or immunosuppressive drugs)Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years (Note: subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment [within the past 2 years] are not excluded)Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment in the past 2 yearsXx_NEWLINE_xXHas active autoimmune disease that has required treatment in the past 2 years.Xx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in the past 2 years (replacement therapies for hormone deficiencies are allowed)Xx_NEWLINE_xXActive autoimmune disease that required systemic treatment in the past. Patients who have not required systemic treatment for at least two years may be enrolled if permission is provided after discussion with the Medical Monitor.Xx_NEWLINE_xXPatients with history of autoimmune disease with certain exceptions such as vitiligo, resolved chilhood atopic dermatitis, psoriasis not requiring systemic therapy within the past 2 years, patients with history of Grave's disease that are now euthyroid clinically and by lab testingXx_NEWLINE_xXActive, known, suspected autoimmune disease requiring systemic treatment in the past 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune or inflammatory disorders within the past 3 years.Xx_NEWLINE_xXParticipants who have an active autoimmune disease requiring systemic treatment within the past 3 months or have a documented history of clinically severe autoimmune disease that requires systemic steroids or immunosuppressive agents.Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; NOTE: subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXHas active or prior documented autoimmune disease within the past 24 monthsXx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment within the 2 years prior to the first dose of study medicationXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years .Xx_NEWLINE_xXActive or prior documented autoimmune or inflammatory disorders within the past 3 years prior to the start of treatmentXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years (replacement therapy is not considered a form of systemic treatmentXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 years; replacement therapy is not considered a form of systemic treatmentXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment within the past 3 months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic or immunosuppressive agentsXx_NEWLINE_xXActive autoimmune disease requiring systemic treatment within the past 3 months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agentsXx_NEWLINE_xXActive autoimmune disease that has required systemic therapy in the past 2 years with modifying agents, corticosteroids, or immunosuppressive agentsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years.Xx_NEWLINE_xXHas an autoimmune disease that has required systemic treatment in the past 2 years with use of disease modifying agents, corticosteroids, or immunosuppressive drugsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 yearsXx_NEWLINE_xXAutoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; Note: subjects with vitiligo, Grave's disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded; rare exceptions allowed with the consent of both principal investigators (Drs. Lee and Sherman)Xx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy is not considered a form of systemic treatment.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs).Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years NOTE: subjects with vitiligo, Graves disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented active autoimmune disease that has required systemic treatment; NOTE: Patients with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excluded; patients with celiac disease controlled with diet modification are not excludedXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 yearsXx_NEWLINE_xXActive autoimmune disease that has required systemic treatment in the past 3 months.Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years NOTE: Subjects with vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 3 yearsXx_NEWLINE_xXHas an active autoimmune disease requiring systemic treatment within the past 3 months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.Xx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 yearsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 yearsXx_NEWLINE_xXActive or prior autoimmune disorder within the past 2 yearsXx_NEWLINE_xXOngoing or recent (within 5 years) evidence of significant autoimmune disease that required treatment with systemic immunosuppressive treatmentsXx_NEWLINE_xXActive or prior documented autoimmune disease within the past 2 years; patients with a history of vitiligo, Grave’s disease, or psoriasis not requiring systemic treatment (within the past 2 years) are not excludedXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy is not considered a form of systemic treatment.Xx_NEWLINE_xXHistory of autoimmune disease with certain exceptions such as vitiligo, resolved childhood atopic dermatitis, psoriasis not requiring systemic therapy within the past 2 years, patients with history of Grave's disease that are now euthyroid clinically and by lab testingXx_NEWLINE_xXActive autoimmune disease requiring systemic therapy in past 2 years (IMGN853 and pembrolizumab only)Xx_NEWLINE_xXNot have gardened in the past 2 gardening seasonsXx_NEWLINE_xXDiagnosis of cancer requiring systemic therapy in the past 5 yearsXx_NEWLINE_xXNot have gardened in the past 2 gardening seasonsXx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in past 2 years.Xx_NEWLINE_xXAutoimmune disease resulting in end-organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollmentXx_NEWLINE_xXPatients with any history of known or suspected autoimmune disease with the specific exceptions of vitiligo, resolved childhood atopic dermatitis, psoriasis not requiring systemic treatment within the past 2 years, and patients with a history of Grave's disease that are now euthyroid clinically and by laboratory testing.Xx_NEWLINE_xXHistory or evidence of active autoimmune disease that has required systemic treatment in the past 2 years (ie, with use of disease modifying agents, corticosteroids or immunosuppressive drugs).Xx_NEWLINE_xXActive autoimmune disease that required systemic treatment in the past.Xx_NEWLINE_xXHas an active autoimmune disease that has required systemic treatment in the past 2 years (e.g., with use of disease modifying agents, corticosteroids, or immunosuppressive drugs).Xx_NEWLINE_xXHave history of or active autoimmune disease, or other syndrome that requires systemic steroids or autoimmune agents for the past 2 years.Xx_NEWLINE_xXActive autoimmune disease that required systemic treatment in the past 2 yearsXx_NEWLINE_xXHas active autoimmune disease that has required systemic treatment in the past 2 years (i.e., with the use of disease modifying agents, corticosteroids, or immunosuppressive drugs).Xx_NEWLINE_xX